Cargando…

Immune Senescence Factors Associated with the Immunogenicity of a Live Attenuated Zoster Vaccine (ZV) in Older Adults

BACKGROUND: ZV confers protection against herpes zoster by increasing the cell-mediated immunity (CMI) to varicella-zoster virus (VZV). ZV immunogenicity and protection decrease with increasing age. We investigated effects of age and immune senescence on ZV immunogenicity. METHODS: 399 adults ≥50 ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinberg, Adriana, Schamder, Kenneth, Johnson, Michael, Popmihajlov, Zoran, Tovar-Salazar, Adriana, Caldas, Yupanqui, Pang, Lei, Cho, Alice, Levin, Myron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631485/ http://dx.doi.org/10.1093/ofid/ofx163.1036

Ejemplares similares

Immunogenicity of Inactivated Varicella Zoster Vaccine (ZV(IN)) in Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Recipients
por: Boeckh, Michael, et al.
Publicado: (2017)

Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines
por: Park, Seong Yeon, et al.
Publicado: (2022)

2027. Immune Correlates of Protection Against Herpes Zoster (HZ) in People Living with HIV (PLWH)
por: Tovar-Salazar, Adriana, et al.
Publicado: (2018)

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer
por: Boeckh, Michael J, et al.
Publicado: (2020)

Recruitment of naive CD4(+) T cells by the recombinant zoster vaccine correlates with persistent immunity
por: Laing, Kerry J., et al.
Publicado: (2023)

Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults
por: Choi, Won Suk, et al.
Publicado: (2016)

Studies of Vector Boson Scattering in the semileptonic ZV channel with the CMS detector at $\sqrt{s}$=13 TeV
por: Singh, Ramanpreet
Publicado: (2022)

Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity
por: Tovar-Salazar, Adriana, et al.
Publicado: (2017)

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
por: Grupping, Katrijn, et al.
Publicado: (2017)

Search for electroweak diboson production in $ ZV \rightarrow llqq \,(V=Z/W) $ final states with the ATLAS detector at the LHC
por: Pinto, Sara
Publicado: (2020)

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine
por: Callegaro, Andrea, et al.
Publicado: (2021)

Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States
por: Suaya, Jose A., et al.
Publicado: (2014)

Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine
por: Lee, Eunyoung, et al.
Publicado: (2018)

Negative Feedback Regulation of T Cells via Interleukin-2 and FOXP3 Reciprocity
por: Popmihajlov, Zoran, et al.
Publicado: (2008)

Humoral and Cellular Immunogenicity of Zoster Vaccine within One Year after Herpes Zoster
por: Lee, Eunyoung, et al.
Publicado: (2017)

5. How Does Frailty Impact the Efficacy, Reactogenicity, Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine? A Secondary Analysis of the ZOE-50 and ZOE-70 Studies
por: Andrew, Melissa K, et al.
Publicado: (2020)

Evaluation of efficacy and effectiveness of live attenuated zoster vaccine
por: GABUTTI, G., et al.
Publicado: (2014)

Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021)

Boosting Immunity in Recipients of Live-Attenuated Zoster Vaccine
por: Schmid, D. Scott
Publicado: (2016)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matched, Clinical Trial
por: Grupping, Katrijn, et al.
Publicado: (2017)

Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature
por: Wang, Lei, et al.
Publicado: (2018)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023)

Vaccination against herpes zoster in developed countries: State of the evidence
por: Drolet, Mélanie, et al.
Publicado: (2013)

Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine
por: Weinberg, Adriana, et al.
Publicado: (2015)

4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
por: Chun, June Young, et al.
Publicado: (2021)

Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination
por: Price, Nathan B., et al.
Publicado: (2021)

Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States
por: Li, Qian, et al.
Publicado: (2016)

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals
por: Curran, Desmond, et al.
Publicado: (2020)

Kommentar zum Kommentar von F. Steger zum Beitrag „Arbeits(zeit)schutz nach Art der BRD – am Beispiel der Covid-19-ArbZV“
por: Nachreiner, Friedhelm
Publicado: (2021)

Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination
por: Hastie, Andrew, et al.
Publicado: (2020)

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children
por: Namazova-Baranova, Leyla, et al.
Publicado: (2021)

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults
por: Ambrose, Christopher S., et al.
Publicado: (2010)

Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
por: Marin, Ines, et al.
Publicado: (2023)

Conditional IL-2 Gene Deletion: Consequences for T Cell Proliferation
por: Popmihajlov, Zoran, et al.
Publicado: (2012)

Nachbesetzung Kassenarztstelle in einem MVZ; kurzfristige Selbstvertretung durch zuvor angestellten Arzt auf vakant gewordener Angestelltenstelle: Ärzte-ZV 32 Abs. 1 S. 5, 32b Abs. 6
Publicado: (2022)

Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature
por: Badur, Selim, et al.
Publicado: (2022)

Safety and Varicella Outcomes in In Utero–Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program
por: Duchon, Jennifer M, et al.
Publicado: (2019)

Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)–Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women
por: Perciani, Catia T, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rolmgj35u6kosfj49csm6kqeub